MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer

MicroRNA-155 是效应 CD8+ T 细胞对病毒感染和癌症作出反应所必需的

阅读:5
作者:Jan C Dudda, Bruno Salaun, Yun Ji, Douglas C Palmer, Gwennaelle C Monnot, Estelle Merck, Caroline Boudousquie, Daniel T Utzschneider, Thelma M Escobar, Rachel Perret, Stefan A Muljo, Michael Hebeisen, Nathalie Rufer, Dietmar Zehn, Alena Donda, Nicholas P Restifo, Werner Held, Luca Gattinoni, Pedro R

Abstract

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。